If you are taking semaglutide (Wegovy) and not losing weight, youre understandably concerned and have questions
Evidence Linking Ozempic to Gastroparesis Risks A recent Ozempic class action lawsuit filed by Suzanne Talbot in the Supreme Court of British Columbia highlights a recent piece of medical research published in The Journal of the American Medical Association (JAMA) in October 2023, which found that Ozempic triples the risk of gastroparesis among users when compared to other oral weight loss medications, while also increasing the risk of pancreatitis and bowel obstruction
Learn more about the Aspen Clinic program and start your journey today
Before starting compounded semaglutide or tirzepatide, review this information with both your neurologist and primary care provider to ensure the timing, dose, and monitoring plan align with your epilepsy management and overall health goals
If traveling internationally, research the destination country's temperature and humiditykeeping your pen in a hotel minibar or requesting refrigeration from the front desk maintains stability during multi-day trips
Better Value Lower doses but longer benefits
